Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rupa R Patel

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
AIDS (London, England)|November 24, 2025
Suboptimal laboratory testing at PrEP initiation in the United States, 2022-2023Weiming Zhu, Ya-Lin A Huang, Rupa R Patel, et al.
MMWR. Morbidity and Mortality Weekly Report|September 18, 2025
Clinical Recommendation for the Use of Injectable Lenacapavir as HIV Preexposure Prophylaxis - United States, 2025Rupa R Patel, Karen W Hoover, Allison Lale, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 14, 2025
Out-of-pocket costs for PrEP ancillary services among U.S. commercially insured persons, 2017-2022Ya-Lin A Huang, Rupa R Patel, Laura M Mann, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 3, 2025
Real-world HIV RNA and antigen/antibody testing among people who use long-acting injectable PrEPWeiming Zhu, Kevin Delaney, Ya-Lin A Huang, et al.
Sexually Transmitted Diseases|February 22, 2018
Improving Insurance and Health Care Systems to Ensure Better Access to Sexually Transmitted Disease Testing and PreventionAlice J Lee, Madeline C Montgomery, Rupa R Patel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 5, 2025
HIV RNA testing to monitor oral PrEP use does not add clinical value: a real-world cohort study-United States, 2019-2023Weiming Zhu, Kevin Delaney, Ya-Lin A Huang, et al.
Open Forum Infectious Diseases|May 27, 2024
High Rates of Missed HIV Testing Among Oral PrEP Users in the United States From 2018-2021: A National Assessment on Compliance With HIV Testing Recommendations of the CDC PrEP GuidelinesJason Baron, Tamar Tchelidze, Benjamin LaBrot, et al.
AIDS and Behavior|January 5, 2022
Preferences for HIV Preexposure Prophylaxis Products Among Black Women in the U.SWhitney C Irie, Sarah K Calabrese, Rupa R Patel, et al.
Plos One|December 29, 2018
Pre-exposure prophylaxis for HIV prevention preferences among young adult African American men who have sex with menRupa R Patel, John S Crane, Julia López, et al.
AIDS Education and Prevention : Official Publication of the International Society for AIDS Education|October 28, 2020
Associations Among HIV Risk Perception, Sexual Health Efficacy, and Intent to Use PrEP Among Women: An Application of the Risk Perception Attitude FrameworkWhitney C Sewell, Rupa R Patel, Stephanie Blankenship, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
AIDS (London, England)|November 24, 2025
Suboptimal laboratory testing at PrEP initiation in the United States, 2022-2023Weiming Zhu, Ya-Lin A Huang, Rupa R Patel, et al.
MMWR. Morbidity and Mortality Weekly Report|September 18, 2025
Clinical Recommendation for the Use of Injectable Lenacapavir as HIV Preexposure Prophylaxis - United States, 2025Rupa R Patel, Karen W Hoover, Allison Lale, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 14, 2025
Out-of-pocket costs for PrEP ancillary services among U.S. commercially insured persons, 2017-2022Ya-Lin A Huang, Rupa R Patel, Laura M Mann, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 3, 2025
Real-world HIV RNA and antigen/antibody testing among people who use long-acting injectable PrEPWeiming Zhu, Kevin Delaney, Ya-Lin A Huang, et al.
Sexually Transmitted Diseases|February 22, 2018
Improving Insurance and Health Care Systems to Ensure Better Access to Sexually Transmitted Disease Testing and PreventionAlice J Lee, Madeline C Montgomery, Rupa R Patel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 5, 2025
HIV RNA testing to monitor oral PrEP use does not add clinical value: a real-world cohort study-United States, 2019-2023Weiming Zhu, Kevin Delaney, Ya-Lin A Huang, et al.
Open Forum Infectious Diseases|May 27, 2024
High Rates of Missed HIV Testing Among Oral PrEP Users in the United States From 2018-2021: A National Assessment on Compliance With HIV Testing Recommendations of the CDC PrEP GuidelinesJason Baron, Tamar Tchelidze, Benjamin LaBrot, et al.
AIDS and Behavior|January 5, 2022
Preferences for HIV Preexposure Prophylaxis Products Among Black Women in the U.SWhitney C Irie, Sarah K Calabrese, Rupa R Patel, et al.
Plos One|December 29, 2018
Pre-exposure prophylaxis for HIV prevention preferences among young adult African American men who have sex with menRupa R Patel, John S Crane, Julia López, et al.
AIDS Education and Prevention : Official Publication of the International Society for AIDS Education|October 28, 2020
Associations Among HIV Risk Perception, Sexual Health Efficacy, and Intent to Use PrEP Among Women: An Application of the Risk Perception Attitude FrameworkWhitney C Sewell, Rupa R Patel, Stephanie Blankenship, et al.
Pageof 5